Global Cancer Angiogenesis Inhibitor Sales Market Report Forecast 2017 to 2022

November 2017 | 119 pages | ID: G033539A8F0EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 CANCER ANGIOGENESIS INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Angiogenesis Inhibitor
1.2 Classification of Cancer Angiogenesis Inhibitor
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cancer Angiogenesis Inhibitor
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Angiogenesis Inhibitor Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Cancer Angiogenesis Inhibitor (2012-2022)
  1.5.1 Global Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2022)
  1.5.2 Global Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON CANCER ANGIOGENESIS INHIBITOR INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 CANCER ANGIOGENESIS INHIBITOR MANUFACTURING COST ANALYSIS

3.1 Cancer Angiogenesis Inhibitor Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cancer Angiogenesis Inhibitor

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cancer Angiogenesis Inhibitor Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cancer Angiogenesis Inhibitor Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL CANCER ANGIOGENESIS INHIBITOR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Cancer Angiogenesis Inhibitor Market Competition by Manufacturers
  5.1.1 Global Cancer Angiogenesis Inhibitor Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Cancer Angiogenesis Inhibitor Revenue and Share by Manufacturers (2012-2017)
5.2 Global Cancer Angiogenesis Inhibitor (Volume and Value) by Type
  5.5.1 Global Cancer Angiogenesis Inhibitor Sales and Market Share by Type (2012-2017)
  5.5.2 Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Type (2012-2017)
5.3 Global Cancer Angiogenesis Inhibitor (Volume and Value) by Regions
  5.3.1 Global Cancer Angiogenesis Inhibitor Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Regions (2012-2017)
5.4 Global Cancer Angiogenesis Inhibitor (Volume) by Application

6 UNITED STATES CANCER ANGIOGENESIS INHIBITOR (VOLUME, VALUE AND SALES PRICE)

6.1 United States Cancer Angiogenesis Inhibitor Sales and Value (2012-2017)
  6.1.1 United States Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
  6.1.2 United States Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
  6.1.3 United States Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
6.2 United States Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers
6.3 United States Cancer Angiogenesis Inhibitor Sales and Market Share by Type
6.4 United States Cancer Angiogenesis Inhibitor Sales and Market Share by Application

7 CHINA CANCER ANGIOGENESIS INHIBITOR (VOLUME, VALUE AND SALES PRICE)

7.1 China Cancer Angiogenesis Inhibitor Sales and Value (2012-2017)
  7.1.1 China Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
  7.1.2 China Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
  7.1.3 China Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
7.2 China Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers
7.3 China Cancer Angiogenesis Inhibitor Sales and Market Share by Type
7.4 China Cancer Angiogenesis Inhibitor Sales and Market Share by Application

8 EUROPE CANCER ANGIOGENESIS INHIBITOR (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Cancer Angiogenesis Inhibitor Sales and Value (2012-2017)
  8.1.1 Europe Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
  8.1.2 Europe Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
8.2 Europe Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers
8.3 Europe Cancer Angiogenesis Inhibitor Sales and Market Share by Type
8.4 Europe Cancer Angiogenesis Inhibitor Sales and Market Share by Application

9 JAPAN CANCER ANGIOGENESIS INHIBITOR (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Cancer Angiogenesis Inhibitor Sales and Value (2012-2017)
  9.1.1 Japan Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
  9.1.2 Japan Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
9.2 Japan Cancer Angiogenesis Inhibitor Sales and Market Share by Manufacturers
9.3 Japan Cancer Angiogenesis Inhibitor Sales and Market Share by Type
9.4 Japan Cancer Angiogenesis Inhibitor Sales and Market Share by Application

10 GLOBAL CANCER ANGIOGENESIS INHIBITOR MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Allergan
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Alnylam Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Amgen
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Angstrom Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Acceleron Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Biocon
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Bionomics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 CASI Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL CANCER ANGIOGENESIS INHIBITOR MARKET FORECAST (2017-2022)

13.1 Global Cancer Angiogenesis Inhibitor Sales, Revenue Forecast (2017-2022)
13.2 Global Cancer Angiogenesis Inhibitor Sales Forecast by Regions (2017-2022)
13.3 Global Cancer Angiogenesis Inhibitor Sales Forecast by Type (2017-2022)
13.4 Global Cancer Angiogenesis Inhibitor Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Angiogenesis Inhibitor
Table Classification of Cancer Angiogenesis Inhibitor
Figure Global Sales Market Share of Cancer Angiogenesis Inhibitor by Type in 2016
Table Applications of Cancer Angiogenesis Inhibitor
Figure Global Sales Market Share of Cancer Angiogenesis Inhibitor by Application in 2016
Figure United States Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2022)
Figure China Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2022)
Figure Europe Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2022)
Figure Japan Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2022)
Figure Global Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2022)
Figure Global Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2022)
Table Global Cancer Angiogenesis Inhibitor Sales of Key Manufacturers (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Sales Share by Manufacturers (2012-2017)
Figure 2015 Cancer Angiogenesis Inhibitor Sales Share by Manufacturers
Figure 2016 Cancer Angiogenesis Inhibitor Sales Share by Manufacturers
Table Global Cancer Angiogenesis Inhibitor Revenue by Manufacturers (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Cancer Angiogenesis Inhibitor Revenue Share by Manufacturers
Table 2016 Global Cancer Angiogenesis Inhibitor Revenue Share by Manufacturers
Table Global Cancer Angiogenesis Inhibitor Sales and Market Share by Type (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Sales Share by Type (2012-2017)
Figure Sales Market Share of Cancer Angiogenesis Inhibitor by Type (2012-2017)
Figure Global Cancer Angiogenesis Inhibitor Sales Growth Rate by Type (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Type (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Angiogenesis Inhibitor by Type (2012-2017)
Figure Global Cancer Angiogenesis Inhibitor Revenue Growth Rate by Type (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Sales and Market Share by Regions (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Sales Share by Regions (2012-2017)
Figure Sales Market Share of Cancer Angiogenesis Inhibitor by Regions (2012-2017)
Figure Global Cancer Angiogenesis Inhibitor Sales Growth Rate by Regions (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Revenue and Market Share by Regions (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Cancer Angiogenesis Inhibitor by Regions (2012-2017)
Figure Global Cancer Angiogenesis Inhibitor Revenue Growth Rate by Regions (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Sales and Market Share by Application (2012-2017)
Table Global Cancer Angiogenesis Inhibitor Sales Share by Application (2012-2017)
Figure Sales Market Share of Cancer Angiogenesis Inhibitor by Application (2012-2017)
Figure Global Cancer Angiogenesis Inhibitor Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
Figure United States Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
Figure United States Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
Table United States Cancer Angiogenesis Inhibitor Sales by Manufacturers (2012-2017)
Table United States Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2012-2017)
Table United States Cancer Angiogenesis Inhibitor Sales by Type (2012-2017)
Table United States Cancer Angiogenesis Inhibitor Market Share by Type (2012-2017)
Table United States Cancer Angiogenesis Inhibitor Sales by Application (2012-2017)
Table United States Cancer Angiogenesis Inhibitor Market Share by Application (2012-2017)
Figure China Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
Figure China Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
Figure China Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
Table China Cancer Angiogenesis Inhibitor Sales by Manufacturers (2012-2017)
Table China Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2012-2017)
Table China Cancer Angiogenesis Inhibitor Sales by Type (2012-2017)
Table China Cancer Angiogenesis Inhibitor Market Share by Type (2012-2017)
Table China Cancer Angiogenesis Inhibitor Sales by Application (2012-2017)
Table China Cancer Angiogenesis Inhibitor Market Share by Application (2012-2017)
Figure Europe Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
Figure Europe Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
Figure Europe Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
Table Europe Cancer Angiogenesis Inhibitor Sales by Manufacturers (2012-2017)
Table Europe Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2012-2017)
Table Europe Cancer Angiogenesis Inhibitor Sales by Type (2012-2017)
Table Europe Cancer Angiogenesis Inhibitor Market Share by Type (2012-2017)
Table Europe Cancer Angiogenesis Inhibitor Sales by Application (2012-2017)
Table Europe Cancer Angiogenesis Inhibitor Market Share by Application (2012-2017)
Figure Japan Cancer Angiogenesis Inhibitor Sales and Growth Rate (2012-2017)
Figure Japan Cancer Angiogenesis Inhibitor Revenue and Growth Rate (2012-2017)
Figure Japan Cancer Angiogenesis Inhibitor Sales Price Trend (2012-2017)
Table Japan Cancer Angiogenesis Inhibitor Sales by Manufacturers (2012-2017)
Table Japan Cancer Angiogenesis Inhibitor Market Share by Manufacturers (2012-2017)
Table Japan Cancer Angiogenesis Inhibitor Sales by Type (2012-2017)
Table Japan Cancer Angiogenesis Inhibitor Market Share by Type (2012-2017)
Table Japan Cancer Angiogenesis Inhibitor Sales by Application (2012-2017)
Table Japan Cancer Angiogenesis Inhibitor Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acceleron Pharma Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bionomics Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Cancer Angiogenesis Inhibitor Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Cancer Angiogenesis Inhibitor Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Angiogenesis Inhibitor
Figure Manufacturing Process Analysis of Cancer Angiogenesis Inhibitor
Figure Cancer Angiogenesis Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of Cancer Angiogenesis Inhibitor Major Manufacturers in 2016
Table Major Buyers of Cancer Angiogenesis Inhibitor
Table Distributors/Traders List
Figure Global Cancer Angiogenesis Inhibitor Sales and Growth Rate Forecast (2017-2022)
Figure Global Cancer Angiogenesis Inhibitor Revenue and Growth Rate Forecast (2017-2022)
Table Global Cancer Angiogenesis Inhibitor Sales Forecast by Regions (2017-2022)
Table Global Cancer Angiogenesis Inhibitor Sales Forecast by Type (2017-2022)
Table Global Cancer Angiogenesis Inhibitor Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals